Daytime Systolic Ambulatory Blood Pressure With a Direct Switch Between Candesartan Monotherapy and the Fixed‐Dose Combination Olmesartan/Amlodipine in Patients With Uncontrolled Essential Hypertension (SEVICONTROL‐1)

Eitemau Tebyg

• Daytime Systolic Ambulatory Blood Pressure With a Two‐Step Switch From Candesartan to Olmesartan Monotherapy and the Fixed‐Dose Combination of Olmesartan/Amlodipine in Patients With Uncontrolled Essential Hypertension (SEVICONTROL‐2)
  gan: Bramlage, Peter, et al.
  Cyhoeddwyd: (2013)
• A Titrate‐to‐Goal Study of Switching Patients Uncontrolled on Antihypertensive Monotherapy to Fixed‐Dose Combinations of Amlodipine and Olmesartan Medoxomil ± Hydrochlorothiazide
  gan: Weir, Matthew R., et al.
  Cyhoeddwyd: (2011)
• Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice
  gan: Bramlage, Peter, et al.
  Cyhoeddwyd: (2010)
• Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice
  gan: Bramlage, Peter, et al.
  Cyhoeddwyd: (2014)
• Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy
  gan: Punzi, Henry, et al.
  Cyhoeddwyd: (2012)